Dealmaking

As dealmakers continue to negotiate the fallout from the economic impact of the COVID-19 health crisis, SS&C Intralinks conducted a second mergers & acquisitions (M&A) survey with dealmakers in Japan.

Recovery? It’s relative — as COVID-19 looms.

"M&A Transactions in Uncertain Times" co-hosted by Divestopedia and SS&C Intralinks brought together legal, private equity and investment banking specialists to talk about M&A dealmaking in the current environment.

Dealmakers are facing challenges in the struggling market on many fronts, particularly delayed, altered or canceled deals. We spoke to lawyer Rainer Kaspar to learn how he is advising his clients during the pandemic.

It's our second BIG award of the year.

After Australia’s stock market posted its largest one-day drop since the financial crisis in March, dealmakers in the region discuss the downturn.

An undisputed legend on the court, he was co-founder and general partner of Bryant Stibel, a firm whose venture capital fund loomed large in tech.

Although mergers and acquisitions (M&A) dealmakers can’t see the future per se, they can anticipate upcoming trends based on history and patterns in the market. I asked my colleagues in Intralinks product marketing to share major predictions for the upcoming year, based on their expert knowledge of the marketplace.

The year saw a variety of transactions, from healthcare megadeals to data analytics acquisitions. A handful of mergers turned heads for their unprecedented size or unexpected liaison. We reviewed the five most interesting deals of 2019, plus a bonus IPO, listed in no particular order.

We asked a group of seasoned Bay Area-based stalwarts about what’s on the horizon for the coming year.